VKH
PACB icon

Virtu KCG Holdings’s Pacific Biosciences PACB Stock Holding History

Virtu KCG Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,199
Closed -$217K – 3687
2016
Q3 		$217K Sell
24,199
-78,634
-76% -$657K 0.01% 2287
2016
Q2 		$723K Buy
+102,833
New +$939K 0.02% 1015
2015
Q4 		– Sell
-24,790
Closed -$91K – 3822
2015
Q3 		$91K Buy
+24,790
New +$121K ﹤0.01% 2857
2014
Q3 		– Sell
-19,324
Closed -$119K – 3930
2014
Q2 		$119K Buy
+19,324
New +$96.7K ﹤0.01% 3255
2014
Q1 		– Sell
-23,418
Closed -$122K – 3924
2013
Q4 		$122K Sell
23,418
-1,021
-4% -$4.69K ﹤0.01% 3379
2013
Q3 		$135K Buy
+24,439
New +$84.8K ﹤0.01% 3285

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Virtu KCG Holdings's PACB Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Pacific Biosciences (PACB) in Q4 2016, closing a stake of 24,199 shares — an estimated $217K sold.

Virtu KCG Holdings first reported a position in PACB in Q3 2013 and held it in 6 quarters. The position peaked at $723K in Q2 2016. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Pacific Biosciences position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 24,199 Pacific Biosciences shares in Q4 2016, an estimated $217K.
  • Virtu KCG Holdings first reported a position in Pacific Biosciences in Q3 2013 and held it in 6 quarters.
  • Virtu KCG Holdings's Pacific Biosciences position peaked at $723K in Q2 2016.
  • 115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.